Gene therapy can make a real impact on global health but we need equitable access, say experts

• The development of new gene therapies designed to treat or cure a range of diseases is rising exponentially.
• Access remains an issue, especially in low- and middle-income countries (LMICs) where disease burden is highest.
• Five clinical experts across LMICs explain what steps need to be taken to realize the potential of gene therapies globally.

Low- and middle-income countries (LMICs) can and should play a leading role in dictating the future of the world’s most advanced healthcare technologies, according to the World Economic Forum’s Accelerating Global Access to Gene Therapies: Case Studies from Low- and Middle-Income Countries white paper.

Gene therapy is at the forefront of modern medicine. By making precise changes to the...

Today's Sponsors

Today's Sponsor